ATE63757T1 - Expression durch verwendung von fusionsgenen fuer proteinproduktion. - Google Patents
Expression durch verwendung von fusionsgenen fuer proteinproduktion.Info
- Publication number
- ATE63757T1 ATE63757T1 AT86104066T AT86104066T ATE63757T1 AT E63757 T1 ATE63757 T1 AT E63757T1 AT 86104066 T AT86104066 T AT 86104066T AT 86104066 T AT86104066 T AT 86104066T AT E63757 T1 ATE63757 T1 AT E63757T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- superoxide dismutase
- host
- heterologous
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71720985A | 1985-03-28 | 1985-03-28 | |
| EP86104066A EP0196056B1 (de) | 1985-03-28 | 1986-03-25 | Expression durch Verwendung von Fusionsgenen für Proteinproduktion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE63757T1 true ATE63757T1 (de) | 1991-06-15 |
Family
ID=24881138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86104066T ATE63757T1 (de) | 1985-03-28 | 1986-03-25 | Expression durch verwendung von fusionsgenen fuer proteinproduktion. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0196056B1 (de) |
| JP (2) | JPH0829096B2 (de) |
| AT (1) | ATE63757T1 (de) |
| CA (1) | CA1260858A (de) |
| DE (1) | DE3679343D1 (de) |
| DK (1) | DK142186A (de) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587759T2 (de) * | 1984-05-11 | 1994-07-07 | Chiron Corp., Emeryville, Calif. | Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion. |
| US6610520B1 (en) | 1985-11-22 | 2003-08-26 | Bio-Technology General Corp. | Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
| US5084390A (en) * | 1987-03-16 | 1992-01-28 | Chiron Corporation | Superoxide dismutase polymers |
| ATE72581T1 (de) * | 1987-03-16 | 1992-02-15 | Chiron Corp | Superoxiddismutase-polymere. |
| DE3854678T2 (de) * | 1987-03-27 | 1996-06-13 | Bio Technology General Corp | Menschliches Mangansuperoxiddismutase und Behandlungsverfahren. |
| DE3714866A1 (de) * | 1987-05-05 | 1988-11-24 | Hoechst Ag | Verfahren zur herstellung von fremdproteinen in streptomyceten |
| US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
| CA1324969C (en) | 1988-05-06 | 1993-12-07 | Jeffrey R. Shuster | High level expression of proteins in yeast |
| AU5184190A (en) * | 1989-02-23 | 1990-09-26 | University Of Ottawa | Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine |
| PT94241A (pt) * | 1989-06-02 | 1991-02-08 | Chiron Corp | Processo para a preparacao de factor calcificacao ossea e de composicoes farmaceuticas que os contem |
| US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| KR920003787B1 (ko) * | 1990-03-05 | 1992-05-14 | 한국과학기술 연구원 | 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법 |
| JPH07108232B2 (ja) * | 1990-10-09 | 1995-11-22 | エム・ディ・リサーチ株式会社 | ペプチド又は蛋白質の製造方法 |
| EP0785273A1 (de) | 1990-11-26 | 1997-07-23 | Genetics Institute, Inc. | Gepaarte basische Aminosäuren konvertierendes Enzym und dafür kodierende DNA Sequenz |
| US5736363A (en) * | 1991-07-29 | 1998-04-07 | British Bio-Technology Limited | IGF-II analogues |
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| US5629167A (en) | 1994-04-19 | 1997-05-13 | Biocine S.P.A. | Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| HRP940432B1 (en) * | 1994-08-05 | 2003-10-31 | Pliva Pharm & Chem Works | Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin |
| ATE350053T1 (de) † | 1994-12-29 | 2007-01-15 | Ferring Int Ct Sa | Herstellung von humaninsulin |
| GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
| AU4904397A (en) | 1996-10-17 | 1998-05-11 | Chiron Corporation | Protease regulator screening assay |
| US20050202499A1 (en) | 1996-10-31 | 2005-09-15 | Billing-Medel Patricia A. | Reagents and methods useful for detecting diseases of the breast |
| EP1900818A3 (de) | 1997-11-06 | 2008-06-11 | Novartis Vaccines and Diagnostics S.r.l. | Neissersche Antigene |
| WO1999036544A2 (en) | 1998-01-14 | 1999-07-22 | Chiron S.P.A. | Neisseria meningitidis antigens |
| GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| EP2261347A3 (de) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Antigene und Zusammensetzungen gegen Neisseria meningitidis |
| CA2372235A1 (en) | 1999-04-30 | 2000-11-09 | Rino Rappuoli | Conserved neisserial antigens |
| GB9911683D0 (en) | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| GB9916529D0 (en) | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| EP1226253A2 (de) | 1999-10-29 | 2002-07-31 | Chiron S.P.A. | Antigene peptide aus neisseria |
| CA2871789C (en) | 2000-01-17 | 2017-04-04 | Novartis Vaccines And Diagnostics S.R.L. | Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| EP1274720A4 (de) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | Albumin enthaltende fusionsproteine |
| ATE439372T1 (de) | 2000-10-27 | 2009-08-15 | Novartis Vaccines & Diagnostic | Nukleinsäuren und proteine von gruppen a und b- streptokokken |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| EP2168596B1 (de) | 2001-12-12 | 2012-05-23 | Novartis Vaccines and Diagnostics S.r.l. | Immunisierung gegen Chlamydia trachomatis |
| PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
| WO2004046177A2 (en) | 2002-11-15 | 2004-06-03 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| ES2306981T3 (es) | 2003-01-31 | 2008-11-16 | N.V. Organon | Metodo para aislamiento de proteinas en condiciones anoxicas. |
| GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
| CA2553955C (en) | 2004-02-10 | 2012-08-28 | Zystor Therapeutics, Inc. | Acid alpha-glucosidase and fragments thereof |
| ATE522541T1 (de) | 2006-06-09 | 2011-09-15 | Novartis Ag | Bakterielle adhäsine konformere |
| US8138318B2 (en) | 2007-09-13 | 2012-03-20 | Abbott Laboratories | Hepatitis B pre-S2 nucleic acid |
| ES2629853T3 (es) | 2008-05-07 | 2017-08-16 | Biomarin Pharmaceutical Inc. | Péptidos de dirección lisosómica y usos de los mismos |
| EP2475376B1 (de) | 2009-06-17 | 2016-03-30 | BioMarin Pharmaceutical Inc. | Formulierungen für lysosomale enzyme |
| WO2014003176A1 (ja) * | 2012-06-29 | 2014-01-03 | 旭化成メディカル株式会社 | プロテインａのｂドメイン変異体を含むポリペプチドが結合された担体からなる吸着材 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
| SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| DE3486216T2 (de) * | 1983-04-25 | 1994-02-17 | Chiron Corp | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren. |
| GB8314362D0 (en) * | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
| DE3410437A1 (de) * | 1984-03-22 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von proteinen |
-
1986
- 1986-03-25 CA CA000504984A patent/CA1260858A/en not_active Expired
- 1986-03-25 EP EP86104066A patent/EP0196056B1/de not_active Expired - Lifetime
- 1986-03-25 DE DE8686104066T patent/DE3679343D1/de not_active Expired - Lifetime
- 1986-03-25 AT AT86104066T patent/ATE63757T1/de not_active IP Right Cessation
- 1986-03-26 DK DK142186A patent/DK142186A/da not_active Application Discontinuation
- 1986-03-28 JP JP61070648A patent/JPH0829096B2/ja not_active Expired - Lifetime
-
1993
- 1993-03-01 JP JP5040008A patent/JP2545686B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0196056A3 (en) | 1987-12-23 |
| JPH0614793A (ja) | 1994-01-25 |
| DK142186A (da) | 1986-09-29 |
| CA1260858A (en) | 1989-09-26 |
| DE3679343D1 (de) | 1991-06-27 |
| EP0196056A2 (de) | 1986-10-01 |
| JP2545686B2 (ja) | 1996-10-23 |
| JPH0829096B2 (ja) | 1996-03-27 |
| JPS61268193A (ja) | 1986-11-27 |
| EP0196056B1 (de) | 1991-05-22 |
| DK142186D0 (da) | 1986-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3679343D1 (de) | Expression durch verwendung von fusionsgenen fuer proteinproduktion. | |
| CA2541651A1 (en) | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | |
| CA2168429A1 (en) | Expression of fusion polypeptides transported out of cytoplasm without leader sequences | |
| EP1027437B8 (de) | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 | |
| ATE81529T1 (de) | Rekombinante fusionsproteine. | |
| ES8602136A1 (es) | Procedimiento para producir hormona de crecimiento de humano | |
| HUT43629A (en) | Process for producing fusion proteins | |
| KR890014738A (ko) | 단백질 합성의 cks 방법 | |
| EP0206783A3 (de) | Expression und Sekretion von Polypeptiden aus Saccharomyces cerevisiae | |
| GR3026176T3 (en) | Protein complexes having factor viii:c activity and production thereof | |
| ATE364703T1 (de) | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen | |
| WO2001051635A3 (en) | Novel stra6 polypeptides | |
| ATE197608T1 (de) | Signalsequenzen für die secretion heterologer proteine von hefe | |
| KR970065558A (ko) | 분비형 Kex2 유도체의 제조방법 | |
| KR930021783A (ko) | 진균 프로테아제 | |
| AU7873798A (en) | N-terminally extended proteins expressed in yeast | |
| DE3686365D1 (de) | Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid. | |
| WO1998022587A3 (en) | Pituitary-tumor-transforming-genes, and related products | |
| ATE46188T1 (de) | Positionsspezifische proteolyse mittels renin. | |
| KR870007280A (ko) | 바실러스에서의 사람 혈청 알부민의 제조방법 | |
| EP0315950A3 (de) | Verfahren zur Züchtung von Zellen, welche rekombinantes Protein exprimieren | |
| SE8802939D0 (sv) | A method for the production and isolation of a fusion protein in eukaryotic cells | |
| EP0750040A3 (de) | Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung | |
| RU92004585A (ru) | Промотор, днк-последовательность, вектор, клетки, способ экспрессии днк | |
| ATE335005T1 (de) | Menschliches protein mit in vitro antiproliferativer aktivität. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |